Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV003053179 | SCV003451770 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2023-06-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004070315 | SCV005017846 | uncertain significance | Cardiovascular phenotype | 2023-11-02 | criteria provided, single submitter | clinical testing | The p.G1444A variant (also known as c.4331G>C), located in coding exon 25 of the FLNC gene, results from a G to C substitution at nucleotide position 4331. The glycine at codon 1444 is replaced by alanine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |